Harel Insurance Investments & Financial Services Ltd. Exelixis, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$6.11 Billion
Q4 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$20.67 - $26.94 $41,340 - $53,880	-2,000 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$16.46 - $27.42 $32,920 - $54,840	2,000 New	2,000 $47,000
Q4 2018 Jan 29, 2019	SELL	$13.65 - $21.8 $68,250 - $109,000	-5,000 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$15.87 - $22.4 $79,350 - $112,000	5,000 New	5,000 $89,000
Q2 2018 Jul 30, 2018	SELL	$18.56 - $22.45 $23,571 - $28,511	-1,270 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$22.15 - $31.89 $886 - $1,275	40 Added 3.25%	1,270 $28,000
Q4 2017 Feb 01, 2018	BUY	$24.23 - $30.93 $18,899 - $24,125	780 Added 173.33%	1,230 $37,000
Q3 2017 Nov 02, 2017	BUY	$23.35 - $29.24 $10,507 - $13,158	450	450 $11,000

Others Institutions Holding EXEL

# of Institutions

564

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

Black Rock Inc. New York, NY

33.5M
Shares

$1.15 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.4M
Shares

$1.01 Billion
0.02% of portfolio
Farallon Capital Management LLC San Francisco, CA

23.4M
Shares

$802 Million
4.16% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.3M
Shares

$523 Million
0.8% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$390 Million
0.02% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account